These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 10565972

  • 41. Neuroprotection by ketamine: a review of the experimental and clinical evidence.
    Hudetz JA, Pagel PS.
    J Cardiothorac Vasc Anesth; 2010 Feb; 24(1):131-42. PubMed ID: 19640746
    [No Abstract] [Full Text] [Related]

  • 42. The rise and fall of NMDA antagonists for ischemic stroke.
    Hoyte L, Barber PA, Buchan AM, Hill MD.
    Curr Mol Med; 2004 Mar; 4(2):131-6. PubMed ID: 15032709
    [Abstract] [Full Text] [Related]

  • 43. -(S)-Alpha-phenyl-2-pyridine-ethanamine Dihydrochloride-, a low affinity uncompetitive N-methyl-D-aspartic acid antagonist, is effective in rodent models of global and focal ischemia.
    Cregan EF, Peeling J, Corbett D, Buchan AM, Saunders J, Auer RN, Gao M, Mccarthy DJ, Eisman MS, Campbell TM, Murray RJ, Stagnitto ML, Palmer GC.
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1412-24. PubMed ID: 9400017
    [Abstract] [Full Text] [Related]

  • 44. The rationale for glutamate antagonists in the treatment of traumatic brain injury.
    Myseros JS, Bullock R.
    Ann N Y Acad Sci; 1995 Sep 15; 765():262-71; discussion 298. PubMed ID: 7486612
    [Abstract] [Full Text] [Related]

  • 45. Current status of neuroprotective agents in the treatment of acute ischemic stroke.
    Lutsep HL, Clark WM.
    Curr Neurol Neurosci Rep; 2001 Jan 15; 1(1):13-8. PubMed ID: 11898495
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Low-affinity NMDA receptor antagonists. The neuroprotective potential of ARL 15896AR.
    Palmer GC, Miller JA, Cregan EF, Gendron P, Peeling J.
    Ann N Y Acad Sci; 1997 Oct 15; 825():220-31. PubMed ID: 9369989
    [No Abstract] [Full Text] [Related]

  • 48. GlycineB antagonists as potential therapeutic agents. Previous hopes and present reality.
    Danysz W, Parsons CG, Karcz-Kubicha M, Schwaier A, Popik P, Wedzony K, Lazarewicz J, Quack G.
    Amino Acids; 1998 Oct 15; 14(1-3):235-9. PubMed ID: 9871467
    [Abstract] [Full Text] [Related]

  • 49. Neuroprotective effects of functional antagonists at the glycine site of the NMDA receptor.
    Trullas R.
    Methods Find Exp Clin Pharmacol; 1997 Oct 15; 19 Suppl A():55-6. PubMed ID: 9403859
    [No Abstract] [Full Text] [Related]

  • 50. Energy restriction negates NMDA receptor antagonist efficacy in ischemic stroke.
    Yoon JS, Mughal MR, Mattson MP.
    Neuromolecular Med; 2011 Sep 15; 13(3):175-8. PubMed ID: 21660587
    [Abstract] [Full Text] [Related]

  • 51. Functional Peptides and Small Molecules in Medicinal Chemistry-Part II.
    Shen G, Li Y, Zhao L, Wu H.
    Curr Top Med Chem; 2019 Sep 15; 19(3):186. PubMed ID: 30950336
    [No Abstract] [Full Text] [Related]

  • 52. AMPA receptor antagonists with additional mechanisms of action: new opportunities for neuroprotective drugs?
    Weiser T.
    Curr Pharm Des; 2002 Sep 15; 8(10):941-51. PubMed ID: 11945140
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Ischemic stroke: treatment on the horizon.
    Giroux C, Scatton B.
    Eur Neurol; 1996 Sep 15; 36(2):61-4. PubMed ID: 8654486
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Investigational NMDA receptor modulators for depression.
    Szewczyk B, Pałucha-Poniewiera A, Poleszak E, Pilc A, Nowak G.
    Expert Opin Investig Drugs; 2012 Jan 15; 21(1):91-102. PubMed ID: 22097925
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Memantine offers new possibilities for the treatment of VaD.
    Winblad B, Kivipelto M.
    Lancet Neurol; 2002 Dec 15; 1(8):469. PubMed ID: 12849324
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.